South Dakota Investment Council’s AstraZeneca AZN Stock Holding History

South Dakota Investment Council’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-46,043	Closed	-$6.11M	–	613
2022 Q1	$6.11M	Sell	46,043 -11,442	-20%	-$1.37M	0.12%	156
2021 Q4	$6.7M	Sell	57,485 -11,750	-17%	-$1.38M	0.11%	169
2021 Q3	$8.32M	Buy	69,235 +1,547	+2%	+$180K	0.15%	141
2021 Q2	$8.11M	Sell	67,688 -12,415	-15%	-$1.36M	0.14%	144
2021 Q1	$7.96M	Buy	+80,103	New	+$8.05M	0.13%	152

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

South Dakota Investment Council's AZN Position: Q2 2022 in Review

South Dakota Investment Council sold out of AstraZeneca (AZN) in Q2 2022, closing a stake of 46,043 shares — an estimated $6.11M sold.

South Dakota Investment Council first reported a position in AZN in Q1 2021 and held it in 5 quarters. The position peaked at $8.32M in Q3 2021. 1,016 funds tracked by Wall St. Rank hold AZN as of Q2 2022.

South Dakota Investment Council reported no remaining AstraZeneca position as of Q2 2022 after selling out during the quarter.
South Dakota Investment Council sold 46,043 AstraZeneca shares in Q2 2022, an estimated $6.11M.
South Dakota Investment Council first reported a position in AstraZeneca in Q1 2021 and held it in 5 quarters.
South Dakota Investment Council's AstraZeneca position peaked at $8.32M in Q3 2021.
1,016 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2022.

Based on South Dakota Investment Council's 13F filing for Q2 2022, filed 11 Aug 2022.